Search results
Pasithea Therapeutics First Quarter 2023 Earnings: US$0.13 loss per share (vs US$0.068 loss in 1Q...
Simply Wall St. via Yahoo Finance· 11 months agoPasithea Therapeutics (NASDAQ:KTTA) First Quarter 2023 Results Key Financial Results Net loss:...
EXCLUSIVE: Pasithea Expands Its Core Therapeutic Pipeline With This Acquisition
Benzinga via Yahoo Finance· 2 years agoPasithea Therapeutics Corp (NASDAQ: KTTA) has acquired Alpha-5 integrin LLC, a privately-held...
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With...
Benzinga via Yahoo Finance· 2 years agoPasithea Therapeutics Corp (NASDAQ: KTTA) has announced results from a preliminary preclinical proof...
EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition
Benzinga via Yahoo Finance· 2 years agoPasithea Therapeutics Corp (NASDAQ: KTTA) has acquired AlloMek Therapeutics LLC, a privately-held...
Here's Why We're Not Too Worried About Pasithea Therapeutics' (NASDAQ:KTTA) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive
Benzinga via Yahoo Finance· 2 years agoInvestor group comprising Camac Partners LLC, Concord Investment Partners Ltd, and Leonite Capital...
Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood
Exec Edge via Yahoo Finance· 9 months agoBy Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has...